Stay updated on Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page
- Check3 days agoChange DetectedA new record-history entry dated November 18, 2026 indicates that the clinical trial’s study status was updated. The site revision also advances to v3.8.1.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe site's footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check32 days agoChange DetectedA notice about NIH website terminology changes and transition updates was added to the page.SummaryDifference0.0%

- Check38 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check45 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check52 days agoChange DetectedA new version 1052 posted on 2026-10-01 updates the study's Contacts/Locations and Study Status. The prior version dated 2026-08-04 was removed.SummaryDifference0.0%

Stay in the know with updates to Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.